Fluid Administration and Fluid Accumulation in the Intensive Care Unit
NCT ID: NCT06258616
Last Updated: 2025-02-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
1000 participants
OBSERVATIONAL
2024-04-01
2025-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Fluid Balance and Body Weight Changes in Critically Ill Adult Patients
NCT04434079
Recovery After ICU Treatment: A Prospective Cohort Study
NCT02599428
Infection Surveillance in Intensive Care Patients
NCT00197847
Fluid Responsiveness Tests in Critically Ill Patients During Admission to the Intensive Care Unit
NCT06729268
Patient Reported Symptoms the First Week After Intensive Care Unit Discharge and up to Hospital Discharge
NCT05266118
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Objectives: To describe fluid administration practices during the entire ICU stay, and provide contemporary epidemiological data on fluid accumulation, fluid removal, risk factors and association with patient outcomes from a worldwide perspective.
Study design: International inception cohort study. Patients will be included during a 14-day inception period to be chosen by each participating site.
Population: Critically ill adult patients (≥ 18 years) with acute admission to the ICU.
Intervention: None. Only routinely available data will be collected.
Study duration: Patients are followed daily until ICU discharge or death for a maximum of 28 days. Follow-up is performed 90 days after ICU admission.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Adults (≥ 18 years).
Exclusion Criteria
* Patients with major burns (≥ 10% of body surface)
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Copenhagen
OTHER
Rigshospitalet, Denmark
OTHER
Nordsjaellands Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Deparment of Intensive care, Nordsjællands hospital
Hillerød, Hillerød, Denmark
Department of Intensive Care, Sygehus Sønderjylland Aabenraa
Aabenraa, , Denmark
Departmen of Intensive Care
Aalborg, , Denmark
Department of Intensive Care, University hospital Aarhus
Aarhus, , Denmark
Department of Intensive Care, Rigshospitalet 4131
Copenhagen, , Denmark
Department of Intensive Care, Bispebjerg
Copenhagen, , Denmark
Department of Intensive Care, Herlev Hospital
Herlev, , Denmark
Department of Intensive Care, Regionshospital Gødstrup
Herning, , Denmark
Department of Intensive Care, Zealand University hospital
Køge, , Denmark
Department of Intensive Care, Regionshospitalet Randers
Randers, , Denmark
Department of Intensive Care, University Hospital Zealand, Roskilde
Roskilde, , Denmark
Department of Intensive Care, Tampere University Hospital
Tampere, , Finland
Department of Intensive Care, Landspitali National University Hospital of Iceland
Reykjavik, , Iceland
Department of Anaesthesiology, Critical Care and Pain Tata Memorial Hospital, Mumbai.
Mumbai, , India
Department of Anaesthesia and Critical Care Vilnuis University Hospital Santariskiu Cinics, Vilnuis
Vilnius, , Lithuania
Department of Intensive Care Wellington Hospital (CCDHB), Newton, Wellington
Wellington, , New Zealand
Department of Intensive Care, Stavanger University Hospital
Stavanger, , Norway
Hospital Clinic of Barcelona
Barcelona, , Spain
Helsingborg Hospital
Helsingborg, , Sweden
Department of Intensive Care, Inselspital
Bern, , Switzerland
General Adult Intensive Care Unit, Critical Care Directorate University Hospital of Wales, Cardiff
Cardiff, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Steffen Christensen
Role: primary
I
Role: primary
Pedro Castro
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FLUID-ICU
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.